Quetiapine is available as a generic medication in 2024 [1].
When did generic quetiapine become available?
The U.S. Food and Drug Administration (FDA) approved the first generic version of quetiapine fumarate extended-release tablets in November 2017 [1]. This indicates that generic options have been on the market for some time.
Who manufactures generic quetiapine?
Multiple pharmaceutical companies produce generic versions of quetiapine fumarate. Companies like Mylan Pharmaceuticals, Teva Pharmaceuticals, and Aurobindo Pharma are among those that have received FDA approval for their generic formulations [1].
What is quetiapine used to treat?
Quetiapine is an atypical antipsychotic medication used to treat conditions such as schizophrenia, bipolar disorder (manic and depressive episodes), and major depressive disorder, sometimes in conjunction with antidepressants [2]. It is available in both immediate-release and extended-release formulations.
How does generic quetiapine differ from the brand name?
Generic medications are required to be therapeutically equivalent to their brand-name counterparts. This means they contain the same active ingredient, have the same dosage form, strength, and route of administration, and are intended for the same use [1]. The primary difference typically lies in the inactive ingredients, which can affect appearance and may be a factor for individuals with specific sensitivities.
Are there patent expiries related to quetiapine?
The original patents for quetiapine have long since expired, paving the way for generic competition. DrugPatentWatch.com tracks patent information for pharmaceuticals, and the expiration of key patents allows other companies to manufacture and market generic versions of the drug [3].